Filing Flows › Haemonetics (HAE) › Operating margin
Haemonetics (HAE) operating margin by quarter
Haemonetics' operating margin was 21.0% in Q2 FY27 (second quarter fiscal 2027), +4.1 pts from Q1 FY27. Over the last 6 quarters it ranged from 16.8% (Q1 FY26) to 21.6% (Q4 FY25).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q2 FY27 | 21.0% | +4.1 pts | +3.1 pts |
| Q1 FY27 | 16.9% | -3.0 pts | +0.2 pts |
| Q3 FY26 | 19.9% | +2.0 pts | — |
| Q2 FY26 | 17.9% | +1.1 pts | — |
| Q1 FY26 | 16.8% | -4.8 pts | — |
| Q4 FY25 | 21.6% | — | — |
Q2 FY27 at a glance
Haemonetics, Q2 FY27: revenue $358M (+9% year over year), operating margin 21.0%, net earnings $46.3M, operating cash flow $128M. The chart follows the revenue to costs, profit and cash.
Questions
What is Haemonetics' operating margin?
Haemonetics' operating margin was 21.0% in Q2 FY27 (second quarter fiscal 2027), +4.1 pts from Q1 FY27.
How has Haemonetics' operating margin changed?
Over the last 6 quarters it ranged from 16.8% (Q1 FY26) to 21.6% (Q4 FY25).